1. |
Dekkers OM, Horváthpuhó E, Jørgensen JO, et al. Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. J Clin Endocrinol Metab, 2013, 98(6): 2277-2284.
|
2. |
Wagner J, Langlois F, Lim DST, et al. Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome: a systematic meta-analysis. Front Endocrinol (Lausanne), 2019, 9: 805.
|
3. |
Broder MS, Neary MP, Chang E, et al. Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States. Pituitary, 2015, 18(3): 283-289.
|
4. |
Amodru V, Ferriere A, Tabarin A, et al. Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome. Eur J Endocrinol, 2023, 188(4): 395-406.
|
5. |
吴遐, 高路, 幸兵. 库欣综合征所致高凝状态的研究进展. 基础医学与临床, 2016, 36(1): 121-124.
|
6. |
赵明伟, 周志安, 边树伟. 以肺栓塞入院的库欣综合征患者1例. 承德医学院学报, 2022, 39(6): 521-522.
|
7. |
孙旭, 卢琳, 冯铭, 等. 库欣综合征伴围手术期肺栓塞临床特点分析. 中国现代神经疾病杂志, 2021, 21(3): 177-184.
|
8. |
Huckhagel T, Atlihan G, Langer F, et al. Prevalence of perioperative asymptomatic venous thromboses of the lower extremity in 30 consecutive patients undergoing transsphenoidal surgery for Cushing's disease. Sci Rep, 2023, 13((1): 3217.
|
9. |
Feelders RA, Nieman LK. Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols. Pituitary, 2022, 25(5): 746-749.
|
10. |
Birdwell L, Lodish M, Tirosh A, et al. Coagulation profile dynamics in pediatric patients with Cushing syndrome: a prospective, observational comparative study. J Pediatr, 2016, 177: 227-231.
|
11. |
Erem C, Nuhoglu I, Yilmaz M, et al. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest, 2009, 32(2): 169-174.
|
12. |
Coelho MC, Santos CV, Vieira Neto L, et al. Adverse effects of glucocorticoids: coagulopathy. Eur J Endocrinol, 2015, 173(4): M11-M21.
|
13. |
van der Pas R, de Bruin C, Leebeek FW, et al. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab, 2012, 97(4): 1303-1310.
|
14. |
Manetti L, Bogazzi F, Giovannetti C, et al. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery. Eur J Endocrinol, 2010, 163(5): 783-791.
|
15. |
Zilio M, Mazzai L, Sartori MT, et al. A venous thromboembolism risk assessment model for patients with Cushing's syndrome. Endocrine, 2016, 52(2): 322-332.
|
16. |
Waqar M, Chadwick A, Kersey J, et al. Venous thromboembolism chemical prophylaxis after endoscopic trans-sphenoidal pituitary surgery. Pituitary, 2022, 25(2): 267-274.
|
17. |
Boscaro M, Sonino N, Scarda A, et al. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab, 2002, 87(8): 3662-3666.
|
18. |
Barbot M, Daidone V, Zilio M, et al. Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing? Pituitary, 2015, 18(4): 487-493.
|
19. |
Babic B, De Roulet A, Volpe A, et al. Is VTE prophylaxis necessary on discharge for patients undergoing adrenalectomy for Cushing syndrome? J Endocr Soc, 2018, 3(2): 304-313.
|
20. |
Suarez MG, Stack M, Hinojosa-Amaya JM, et al. Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study. J Endocr Soc, 2019, 4(2): bvz033.
|
21. |
Ferrante E, Serban AL, Clerici M, et al. Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of disease. J Endocrinol Invest, 2022, 45(1): 9-16.
|
22. |
Stuijver DJ, van Zaane B, Feelders RA, et al. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study. J Clin Endocrinol Metab, 2011, 96(11): 3525-3532.
|
23. |
McLeod MK. Complications following adrenal surgery. J Natl Med Assoc, 1991, 83(2): 161-164.
|
24. |
Fukuoka H, Takeuchi T, Matsumoto R, et al. D-dimer as a significant marker of deep vein thrombosis in patients with subclinical or overt Cushing's syndrome. Endocr J, 2014, 61(10): 1003-1010.
|
25. |
van Haalen FM, Kaya M, Pelsma ICM, et al. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet J Rare Dis, 2022, 17(1): 178.
|
26. |
中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南. 中华医学杂志, 2018, 98(14): 1060-1087.
|